This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
27-30 April 2026
Vienna Congress & Convention CenterVienna, Austria
Book Now
Menu
Book
Key Sessions
Thomas Van Cangh
The European Biotech Act: What’s in it for the European Biotech sector?
European Commission
Daniela Ottini
Reimagining the Future of Biopharma Manufacturing & Supply: The Sanofi Modulus Example and Beyond
Sanofi
keyboard_arrow_right

Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)

keyboard_arrow_leftSearch & Filter
search
Main Conference Day 1 (28th April 2026) - CET/CEST (Cent Europe Summer, GMT+2)
search
Showing 1 of 1 Streams
08:55 - 09:00
Chairperson's Opening Remarks
  • Thibaut Angevin - Director CMC Proteins, BioNTech SE
09:00 - 09:30
AI for Pharma/Biotech: Moral Compass Within
  • Kat Kozyrytska - Founder, Cell Therapy Manufacturability Program
09:30 - 10:00
A Practical Roadmap for Harmonising Data to Optimise your Processes
  • Francisca Gouveia - Innovation Data & Digital Lead, Novartis, France
10:00 - 10:30
Scientific Spotlight: Lonza
Showing 1 of 1 Streams
11:15 - 11:45
Bridging the Scale Gap: Scaling bioprocesses by AI generated 3D printed bioreactors mimicking large scale conditions
  • Peter Satzer - Founder & CTO, print4biotech (p4b)
11:45 - 12:15
From Data to Decisions: AI vs. ML in Bioprocess Optimization – Showcases and Solution Paths

This presentation explores how Artificial Intelligence and Machine Learning contribute differently to modern bioprocess optimization. Five industrially relevant showcases will be discussed - spanning upstream and downstream processes, from monoclonal antibodies to viral vectors, and from small-scale development to manufacturing scale. Emphasis will be placed on the digital transformation journey from manual development work toward fully autonomous biomanufacturing, highlighting solution paths that enable faster, more consistent, and intelligent process optimization across the product lifecycle.

  • Mark Duerkop - Chief Executive Officer, Novasign, Austria
12:15 - 12:45
Scientific Spotlight: Benchling
Pre-Con Workshop Day (27th April 2026)
NextMain Conference Day 2 (29th April 2026)
Filter
Streams
Clear
Choose Day